Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Varchetta

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|August 27, 2002
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairmentGiulia Marchetti, Luca Meroni, Stefania Varchetta, et al.
Plos Pathogens|July 12, 2008
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individualsManuela Fogli, Domenico Mavilio, Enrico Brunetta, et al.
International Journal of Molecular Sciences|September 28, 2023
Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in ElderlyDaniela Dalla Gasperina, Giovanni Veronesi, Carlo M Castelletti, et al.
Journal of Hepatology|December 17, 2008
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantationStefania Varchetta, Barbara Oliviero, M Francesca Donato, et al.
Journal of Viral Hepatitis|July 6, 2021
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis CStefania Varchetta, Dalila Mele, Roberta D'Ambrosio, et al.
Cancers|August 26, 2022
Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK CellsStefania Mantovani, Stefania Varchetta, Dalila Mele, et al.
Gut|December 18, 2015
Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infectionStefania Varchetta, Dalila Mele, Andrea Lombardi, et al.
Frontiers in Immunology|September 22, 2025
Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infectionStefania Varchetta, Federica Sole Golfetto, Patrizia Bono, et al.
Advances in Therapy|May 5, 2026
Increased Adiposity and Dyslipidemia in Young Men Living with HIV Compared to Matched PrEP Users: A Cross-Sectional StudyFelice Cinque, Arianna Liparoti, Stefania Varchetta, et al.
Oncoimmunology|February 28, 2022
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinomaBarbara Oliviero, Stefania Varchetta, Dalila Mele, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|August 27, 2002
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairmentGiulia Marchetti, Luca Meroni, Stefania Varchetta, et al.
Plos Pathogens|July 12, 2008
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individualsManuela Fogli, Domenico Mavilio, Enrico Brunetta, et al.
International Journal of Molecular Sciences|September 28, 2023
Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in ElderlyDaniela Dalla Gasperina, Giovanni Veronesi, Carlo M Castelletti, et al.
Journal of Hepatology|December 17, 2008
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantationStefania Varchetta, Barbara Oliviero, M Francesca Donato, et al.
Journal of Viral Hepatitis|July 6, 2021
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis CStefania Varchetta, Dalila Mele, Roberta D'Ambrosio, et al.
Cancers|August 26, 2022
Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK CellsStefania Mantovani, Stefania Varchetta, Dalila Mele, et al.
Gut|December 18, 2015
Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infectionStefania Varchetta, Dalila Mele, Andrea Lombardi, et al.
Frontiers in Immunology|September 22, 2025
Reduced spike specific T-cell responses in COVID-19 vaccinated subjects undergoing SARS-CoV-2 breakthrough infectionStefania Varchetta, Federica Sole Golfetto, Patrizia Bono, et al.
Advances in Therapy|May 5, 2026
Increased Adiposity and Dyslipidemia in Young Men Living with HIV Compared to Matched PrEP Users: A Cross-Sectional StudyFelice Cinque, Arianna Liparoti, Stefania Varchetta, et al.
Oncoimmunology|February 28, 2022
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinomaBarbara Oliviero, Stefania Varchetta, Dalila Mele, et al.
Pageof 5